First Time Loading...

Prelude Therapeutics Inc
NASDAQ:PRLD

Watchlist Manager
Prelude Therapeutics Inc Logo
Prelude Therapeutics Inc
NASDAQ:PRLD
Watchlist
Price: 4.12 USD 3%
Updated: May 21, 2024

Income Statement

Earnings Waterfall
Prelude Therapeutics Inc

Revenue
0 USD
Operating Expenses
-137.5m USD
Operating Income
-137.5m USD
Other Expenses
12m USD
Net Income
-125.5m USD

Income Statement
Prelude Therapeutics Inc

Rotate your device to view
Income Statement
Currency: USD
Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(59)
(60)
(87)
(100)
(114)
(122)
(124)
(123)
(124)
(122)
(125)
(128)
(132)
(138)
Selling, General & Administrative
(11)
(13)
(19)
(24)
(27)
(29)
(32)
(31)
(31)
(30)
(30)
(29)
(29)
(29)
Research & Development
(48)
(46)
(69)
(76)
(87)
(93)
(92)
(92)
(93)
(92)
(96)
(99)
(103)
(109)
Operating Income
(59)
N/A
(60)
-1%
(87)
-47%
(100)
-15%
(114)
-14%
(122)
-7%
(124)
-1%
(123)
+0%
(124)
0%
(122)
+1%
(125)
-2%
(128)
-2%
(132)
-3%
(138)
-4%
Pre-Tax Income
Total Other Income
2
2
3
2
2
2
3
4
8
9
9
11
10
12
Pre-Tax Income
(57)
N/A
(57)
-1%
(84)
-47%
(98)
-17%
(112)
-14%
(120)
-7%
(120)
0%
(120)
+1%
(115)
+4%
(114)
+2%
(117)
-3%
(117)
-1%
(122)
-4%
(126)
-3%
Net Income
Income from Continuing Operations
(57)
(57)
(84)
(98)
(112)
(120)
(120)
(120)
(115)
(114)
(117)
(117)
(122)
(126)
Net Income (Common)
(57)
N/A
(57)
-1%
(84)
-47%
(98)
-17%
(112)
-14%
(120)
-7%
(120)
0%
(120)
+1%
(115)
+4%
(114)
+2%
(117)
-3%
(117)
-1%
(122)
-4%
(126)
-3%
EPS (Diluted)
-4.56
N/A
-1.27
+72%
-1.82
-43%
-2.11
-16%
-2.43
-15%
-2.54
-5%
-2.54
N/A
-2.54
N/A
-2.44
+4%
-2.39
+2%
-2.07
+13%
-1.73
+16%
-2.02
-17%
-1.65
+18%

See Also

Discover More